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Body Fat Distribution and Male/Female
Differences in Lipids and Lipoproteins
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The role of body fat distribution, as assessed by the ratio of waist-to-hip circumferences (WHR),
in statistically explaining differences in levels of lipoproteins between men and women was
studied using data collected in 1985-1986 from employed adults (mean age, 40 years). As
compared with the 415 women, the 709 men had higher mean levels of triglycerides (+38 mg/dl)
and apolipoprotein B (+11 mg/dl) as well as lower mean levels of high density lipoprotein
(HDL) cholesterol (-15 mg/dl) and apolipoprotein A-I (-19 mg/dl). Additionally, men were
more overweight, consumed more alcohol, and exercised more frequently than women but were
less likely to smoke cigarettes. Controlling for these characteristics, however, did not alter the
differences in lipoprotein levels between men and women. In contrast, adjustment for WHR
(which was greater among men) reduced the sex differences in levels of apolipoprotein B (by
98%), triglycerides (by 94%), HDL cholesterol (by 33%), and apolipoprotein A-I (by 21%).
Similar results were obtained using analysis of covariance, stratification, or matching; at
comparable levels ofWHR, differences in lipid and lipoprotein levels between men and women
were greatly reduced. Although these results are based on cross-sectional analyses of employed
adults and need to be replicated in other populations, the findings emphasize the relative
importance of body fat distribution. Whereas generalized obesity and body fat distribution are
associated with lipid levels, fat distribution (or a characteristic influencing fat patterning) can
be an important determinant of sex differences in levels of triglycerides, HDL cholesterol, and
apolipoproteins B and A-I. (Circulation 1990;81:1498-1506)
W omen in Westernized countries have a
much lower incidence of coronary heart
disease than do men.1'2 Determinants of
this sex differential have recently received increased
attention,3,4 and evidence suggests that it might be, in
part, because of male/female differences in levels of
lipids and lipoproteins. Although the standard risk
factors for coronary heart disease are at least as
important among women as men,25 relatively low
levels of triglycerides and high levels of high density
lipoprotein (HDL) cholesterol might protect most
women from developing extensive atherosclerosis.
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In contrast, in societies with low rates of coronary
heart disease, sex differences in levels of HDL
cholesterol,6 coronary atherosclerosis,7 and mortality
from coronary heart disease8 are greatly reduced.
Furthermore, data from the Framingham Study show
that about 15% of the male excess in coronary heart
disease among 45-54-year-old subjects can be attrib-
uted to levels of total cholesterol and nonlipid risk
factors,5 and sex differences in coronary heart disease
are reduced if comparisons are made at similar levels
of total/HDL cholesterol.9 One half of the increased
risk of coronary heart disease among men might be
because of adverse levels of total cholesterol, glucose,
and behavioral characteristics.10
Although obesity is an important determinant of
lipoprotein levels, the distribution of body fat is also
critical." Vague'2 was the first to observe that women
with upper-body obesity, the pattern usually seen in
men, are more likely to have diabetes and atheroscle-
rosis than are women with lower-body obesity. More
recently, body fat distribution, as assessed by various
skinfold and circumference measurements, has been
related to diabetes and coronary heart disease.13'14
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Independent of the general overweight level, the
ratio of waist-to-hip circumferences (WHR) is asso-
ciated with adverse levels of lipids, lipoproteins, and
insulin,'1516 and is predictive of coronary heart
disease.'7,"8
Although men have higher levels of WHR than
women, the role of body fat distribution in explaining
male/female differences in levels of lipids and lipo-
proteins has not been assessed. We have previously
shown that WHR is independently related to lipid
and lipoprotein levels in men and women.16 The
objective of the present study was to determine
whether levels ofWHR in this sample can explain the
sex differentials in levels of HDL cholesterol, triglyc-
erides, and apolipoproteins A-I and B.
Methods
Study Population
Participants were primarily white-collar workers who
volunteered for serum lipid screenings at their places of
employment (two Milwaukee companies) from June
1985 through March 1986. As previously reported,16
approximately 50% of all eligible persons participated
in these examinations and completed a questionnaire
concerning various behavioral characteristics. The
majority of participants worked in professional or man-
agerial positions, and men were more likely to take part
in the examinations than women. Informed consent was
obtained, and the study protocol was approved by the
Human Research Review Committee of the Medical
College of Wisconsin.
The study was restricted to 1,124 (709 men and 415
women) white 20-69-year-old subjects. Other racial
groups represented less than 5% of all participants
and were excluded from the analyses, as were 11
persons who had been told by a physician that they
were diabetic. Because of their effects on lipoprotein
levels, subjects who reported while using lipid-
lowering medications (n=4) or oral contraceptives
(n= 110) were also excluded.
General Examinations
Anthropometric measurements were taken in a
uniform manner by trained personnel, with partici-
pants wearing light clothing during the examination.
Weight and height were obtained using calibrated
balance scales, and Quetelet index (kg/m') was cal-
culated as a measure of weight relative to height.19
Waist circumference was measured at the navel, and
hip circumference was measured at the widest part of
the hips and buttocks. Because circumference mea-
surements were made in inches, this scale is used
throughout the analyses.
Information on alcohol intake, smoking, exercise,
and oral contraceptive use were obtained from a
questionnaire that has been extensively used in
patients undergoing coronary arteriography.20 Usual
weekly alcohol intake was expressed as milliliters of
absolute alcohol by using values of 4% for beer, 12%
for wine, and 43% for liquor. Exercise was a count of
the number of times per month that each person
participated in aerobic exercise. Information was not
collected on use of postmenopausal hormones; how-
ever, analyses were performed to assess the effects of
controlling for WIR among subjects who were 50
years old or younger, or more than 50 years old.
Laboratory Analyses
Ten milliliters of blood were drawn by venipunc-
ture after an overnight fast. Plasma levels of total
cholesterol and triglycerides were measured by auto-
mated procedures,21-23 with quality control moni-
tored by the Centers for Disease Control. HDL
cholesterol was measured after heparin-manganese
precipitation of other lipoproteins, according to pro-
cedures developed by the Lipid Research Clinics.23
The total-to-HDL-cholesterol ratio was used as a
measure of the atherogenicity of the lipoprotein
profile.
Plasma levels of apolipoprotein B were measured by
an enzyme-linked immunoassay24; levels were in the
range of 22-170 mg/dl, with mean levels of 81 and 70
mg/dl among men and women, respectively. Apolipo-
protein A-I was measured by a rate immunonephelo-
metric assay with the Beckman Array-Specific Protein
Analysis System25; levels were in the range of 74-222
mg/dl (mean, 125 mg/dl) among men and 77-258 mg/dl
(mean, 144 mg/dl) among women.
Statistical Methods
Because the distributions of several variables (e.g.,
triglycerides) were skewed, various transformations
were used. With the exception of one triglyceride
value (1,580 mg/dl) that was considered an outlier
and was deleted, four missing apolipoprotein B lev-
els, and 17 missing apolipoprotein A-I values, all
subjects had recorded levels for the anthropometric,
behavioral, and lipid measurements. Allp values are
two sided.
Levels of selected characteristics were first con-
trasted between men and women using Wilcoxon and
,v tests. The coefficient of variation (SD . mean) was
used to compare the relative variability ofWHR and
Quetelet index. Interrelations among the anthropo-
metric measures were examined, as was the relation
of these variables to lipid and lipoprotein levels.
Pearson and Spearman correlations yielded similar
results, and only the former are presented.
To assess the relative importance of each anthro-
pometric measurement in explaining the sex differ-
ences in lipid and lipoprotein levels, several regres-
sion models were constructed. (Because levels of
total cholesterol did not differ between men and
women, they were not included in these analyses.)
Male/female differences in levels of lipids and lipo-
proteins were assessed using F tests26 after adjust-
ment for 1) only the covariates (i.e., age, cigarette
smoking, alcohol consumption, and exercise), 2)
covariates and Quetelet index, and 3) covariates and
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TABLE 1. Mean Levels of Selected Characteristics by Age and Sex
Age group
c40 yr >40 yr
Men Women Men Women
Characteristics (n=414) (n=252) (n =295) (n= 163)
Age (yr) 32+5 32-+-5 50±7 51+7
Total cholesterol (mg/dl) 195±42 187±36 215±43 224±54
Triglycerides (mg/dl) 104±70* 70±33* 137±90* 95±52*
HDL cholesterol (mg/dl) 48±12* 60±14* 47±13* 66±20*
Total/HDL cholesterol 4.3±1.6* 3.3±1.1* 4.9±1.7* 3.6±1.2*
ApoB (mg/dl) 77±21* 65±18* 87±23* 78±24*
Apo A-I (mg/dl) 124+19* 139±23* 127±22* 152±32*
Quetelet index (kg/M2) 25.2±3.3* 24.1±4.7* 26.4±3.3t 25.7±5.1t
Waist (in.) 35±4* 29±5* 37±3* 31±5*
Hip (in.) 41±3* 39±4* 42±3* 41±4*
WHR 0.86±0.05* 0.75±0.06* 0.90+0.04* 0.76±0.06*
Alcohol consumption (ml/wk) 125±130* 76±82* 136±146* 75+88*
Exercise (times/wk) 10±9* 7±8* 8±9* 4±6*
Current smoker (%) 13t 23t 16 22
Values are mean±SD. HDL, high density lipoprotein; apo B, apolipoprotein B; apo A-I, apolipoprotein A-I; WHR,
waist-to-hip ratio.
*p<O.OOl; tp<0.01. p values are for equality of means between men and women (within each age group) and were
calculated using either Wilcoxon or x2 tests.
WHR. Male/female differences in lipid and lipopro-
tein levels were also examined within strata of WHR.
Additionally, men and women were matched on
WHR (to the nearest 0.01), and paired t tests were
used to assess differences in lipoprotein levels among
these 118 pairs.
Results
Descniptive Characteristics
Mean ages of men and women were similar (men,
40 years; women, 39 years), and levels of selected
characteristics are shown in Table 1. With the excep-
tion of total cholesterol, all lipid and lipoprotein
levels differed significantly between the sexes. Over-
all, men had higher levels of triglycerides (+38
mg/dl), total/HDL cholesterol (+1.2), and apolipo-
protein B (+11 mg/dl) but lower levels of HDL
cholesterol (-15 mg/dl) and apolipoprotein A-I
(-13 mg/dl). Furthermore, these differences were
virtually identical for both age groups, and similar
results were obtained by various transformations
(e.g., the geometric means for triglycerides differed
by 29 mg/dl). Men also consumed more alcohol and
exercised more frequently than women; however, a
smaller proportion reported smoking cigarettes.
Mean levels of the anthropometric measures were
higher in men, with WHR showing the largest (14%)
proportional difference. This difference in WHR,
together with its low variability (coefficient of variation,
6-8%), resulted in a marked separation ofWHR levels
between the sexes (Figure 1). Although WHR was in
the range of 0.58-1.02, there was overlap between men
and women only from 0.75 to 0.94. Overall, the 25th
percentile among men was approximately equal to the
90th percentile among women (levels of 0.85 and 0.84,
respectively), and similar differences were seen within
each decade of age (data not shown). Although mean
values of Quetelet index also differed (p<0.001)
between men and women, there was more overlap for
this measure; its coefficient of variation was in the
range of 13-20%.
Bivariate Associations
The anthropometric measures were highly interre-
lated (Table 2). The correlation between waist and
hip girths was 0.86, and although Quetelet index was
highly correlated with both circumferences, its corre-
lation with WHR was weaker (r=0.55 and 0.46, men
and women, respectively). Additionally, age was
moderately related to all anthropometric measures
(r=0.12-0.39). The behavioral characteristics (i.e.,
cigarette smoking, alcohol consumption, and exer-
cise) were also associated with the anthropometric
measures; however, correlations were generally
weaker than those shown in Table 2. For example,
WHR was inversely related to exercise (r= -0.34 and
-0.12, men and women, respectively), and current
smokers had slightly higher levels of WHR than
nonsmokers, that is, 0.890 versus 0.876, respectively
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FIGURE 1. Plottings showing comparison of waist-to-hip
ratio (WHR) and Quetelet index between men and women.
Distinct separation of WHR levels between the two sexes is
evident (panel A); however, levels of Quetelet index show
much more overlap (panel B).
(p=0.01, men), and 0.760 versus 0.752 (p=0.30,
women) (data not shown). Alcohol consumption was
inversely related to Quetelet index among women but
not men.
With the exception of HDL cholesterol among
men, levels of lipids and lipoproteins were moder-
ately related to age (Table 3). Stronger associations,
however, were seen with the anthropometric mea-
sures. Correlations with triglycerides tended to be
strongest (reaching r=0.40, with waist girth in wom-
en), whereas associations with apolipoprotein A-I
were weakest. Because of the strong intercorrelations
among the anthropometric measures, however, lipid
and lipoprotein levels were related similarly to
Quetelet index, waist and hip girths, and WHR. For
example, the relation of triglyceride levels to these
measures ranged from 0.28 (hip girth) to 0.39 (waist
girth) in men. Of the behavioral characteristics,
alcohol consumption was positively correlated with
levels of HDL cholesterol and apolipoprotein A-I,
whereas exercise was inversely related to levels of
triglycerides and apolipoprotein B. Furthermore, cig-
arette smokers tended to have higher levels of tri-
glycerides and apolipoprotein B but lower levels of
HDL cholesterol than nonsmokers (data not shown).
Sex Differences in Body Fat Distribution and Lipids
To assess the importance of each anthropometric
measure in statistically explaining the male/female
differences in lipid and lipoprotein levels, several
regression models were constructed. Unadjusted
male/female differences in lipoprotein levels and the
effect of controlling for various characteristics are
shown in Table 4. Adjusting for age, alcohol con-
sumption, exercise, and cigarette smoking slightly
TABLE 2. Intercorrelations* Among the Explanatory Variables
Variable Sext Age Quetelet index Waist Hip WHR
Age
Men ... ...
Women ...
Quetelet index
Men 0.18t
Women 0.20t ...
Waist
Men 0.29* 0.84*
Women 0.25* 0.89* ...
Hip
Men 0.12§ 0.81t 0.86* ...
Women 0.20t 0.91* 0.86t
WHR
Men 0.39* 0.55t 0.78* 0.36* ...
Women 0.22* 0.46t 0.73t 0.29t ...
WHR, waist-to-hip ratio.
*Pearson correlation coefficients; t709 men, 415 women; tp<0.001; §p<0.01.
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TABLE 3. Bivariate Relation* of the Explanatory Variables to Lipid and Lipoprotein Levels
Variable Sex Total cholesterol Triglyceridest HDL cholesterol Total/HDL cholesterol Apo B Apo A-I
Age
Men 0.28:: 0.214: 0 0.174 0.244: 0.11§
Women 0.47i: 0.29t 0.164 0.22: 0.384: 0.24:
Quetelet index
Men 0.244 0.35: -0.21: 0.324 0.254 -0.12§
Women 0.15§ 0.30: -0.20t 0.294: 0.234 -0.11§
Waist
Men 0.29: 0.394 -0.22:t 0.36:: 0.314 -0.164:
Women 0.22: 0.404 -0.20: 0.324 0.304 -0.08
Hip
Men 0.224: 0.284: -0.154: 0.264 0.214 -0.12§
Women 0.12 0.28t -0.174: 0.234 0.18t -0.09
WHR
Men 0.274 0.37: -0.224 0.354 0.304: -0.144:
Women 0.264 0.384 -0.14§ 0.304: 0.344 -0.03
HDL, high density lipoprotein; apo B, apolipoprotein B; apo A-I, apolipoprotein A-I; WHR, waist-to-hip ratio.
*Pearson correlation coefficients, 709 men and 415 women; tvalues have been log transformed; 4p<0.001; §p<0.01.
increased the magnitude of the differences between among persons with a WHR of 0.84-0.87, mean
men and women; and even after controlling for triglyceride levels differed by only 1 mg/dl, mean
Quetelet index, large contrasts were still evident. levels of total/HDL cholesterol differed by only 0.2,
(Adjustment for age alone did not alter the unad- and mean levels of apolipoprotein B were identical
justed values.) Controlling for waist girth, however, in men and women. Furthermore, these similarities
reduced the male/female differences in levels of in lipid and lipoprotein levels existed despite large
triglycerides (from 38 to 10 mg/dl), total/HDL cho- differences in relative weight; as compared with
lesterol (from 1.2 to 0.7), and apolipoprotein B (from men, mean levels of Quetelet index were 2.4-5.2
11 to 4 mg/dl); additional decreases were seen with kg/m2 higher among women in the upper three
adjustment for hip girth. The effects of adjusting for strata of WHR. (Although male/female contrasts in
WHR were comparable to using waist and hip girths lipid and lipoprotein levels were still seen at WHR
sa e wh d i rg fm %p levels of less than 0.79, male/female differences inseparately, with reductions ranging from 21%/ (apo- WHR persisted within this group.) The adjusted
lipoprotein A-I) to 98% (apolipoprotein B). differ sisTe 5, far r oup.)T he te
Stratification was also used to control for differ- differences (Table 5, far right column) show theStratificai ole sof lsoR usedtoe ntrol wor fer- male/female differences in levels of lipids and lipo-ences in levels of WHR between men and women proteins that would be expected if men and women
(Table5).rMale/female differences inlevels oflipids were similarly distributed across the four WHR
and lipoproteins were again reduced, with triglyc- groups. (In contrast, 78% of the women were in the
erides, total/HDL cholesterol, and apolipoprotein lowest WHR group, whereas 51% of the men were
B showing the largest reductions. For example, in the highest category.)
TABLE 4. Sex Differences in Levels of Lipids and Lipoproteins After Adjustment for Selected Characteristics
Male excess levels (mg/dl)
Characteristic controlled for Triglycerides HDL cholesterol Total/HDL cholesterol Apo B Apo A-I
None 384 - 154 1.2t 11:t -194:
Covariates* 424: -174 1.3: 124 -234:
Covariates plus Quetelet index 374 -164 1.2: 11t -224:
Covariates plus waist 10 -124 0.74 4 -17t
Covariates plus waist and hip 0 -11: 0.54: 1 -16:
Covariates plus WHR -2 -104 0.4§ 0 -154
Change in male/female differencet (%) 94 33 66 98 21
Multiple R2 0.17 0.28 0.26 0.20 0.24
HDL, high density lipoprotein; apo B, apolipoprotein B; apo A-I, apolipoprotein A-I; WHR, waist-to-hip ratio.
*Covariates: age, age2, alcohol intake, exercise, and current smoking status.
t(Unadjusted difference-adjusted difference)/unadjusted difference. Levels are adjusted for covariates and WHR.
4:p<O.OOl; §p<0.01. p values are for equality of means between men and women.
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TABLE 5. Mean Levels of Selected Characteristics Stratified by WHR
Levels of WHR Male/female difference
Sex <0.79 0.79-0.83 0.84-0.87 .0.88 Unadjusted Adjusted*
n
Men 24 111 209 365
Women 322 49 24 20 ... ...
Quetelet index (kg/m2)
Men 23.5 23.6 24.4 27.3
Women 23.6 27.7 29.6 29.7 ...
WHR
Men 0.78 0.82 0.86 0.92 ...
Women 0.73 0.81 0.85 0.90
Triglycerides (mg/dl)
Men 87±43 81±37 112±85 135±87
Women 72±35 97±39 111±70 131±58 38t -1
HDL cholesterol (mg/dl)
Men 52±11 52±12 49±14 45±12
Women 64±16 57±18 54±15 61±16 -15t -9t
Total/HDL cholesterol
Men 3.8±0.9 3.8±1.1 4.3±1.6 5.0±1.8
Women 3.2±1.1 4.1±1.1 4.1±1.1 3.9±1.1 1.2t 0.3
Apo B (mg/dl)
Men 72±20 70±18 78±28 87±23
Women 66±19 82±22 78±22 86±27 lit -3
Apo A-I (mg/dl)
Men 126±18 129±20 125+20 124±21
Women 145±28 141±27 136±25 151+28 -19t -16t
Values are mean±SD.
WHR, waist-to-hip ratio; HDL, high density lipoprotein; apo B, apolipoprotein B; Apo A-I, apolipoprotein A-I.
*Values have been adjusted for differences in distribution of men and women across four WIHR categories.
tp<U.UU1; p values are for equality of means between men and women, and were calculated using F tests.
Because of the possible effects of sex hormone
used on these results, similar analyses were per-
formed within categories of age, using 50 years as a
cutoff. Adjusting for WHR reduced the sex differ-
ences in levels of the lipids and lipoproteins within
each age group. For example, a 15-mg/dl male/
female difference in mean levels of HDL cholesterol
was reduced to 9 mg/dl among the 921 younger
subjects; among the 202 persons more than 50 years
old, the differential was reduced from 14 to 5 mg/dl.
Men and women were then matched on WHR (to
the nearest 0.01), resulting in 118 pairs with a mean
WHR of 0.83. Despite women being more overweight
(+3.5 kg/M2) than men in these matched pairs,
male/female differences were reduced for levels of
triglycerides (to 4 mg/dl), HDL cholesterol (to 7
mg/dl), total/HDL cholesterol (to 0.6), and apolipo-
protein A-I/HDL cholesterol (to 0.01).
Discussion
Although it is uncertain why men in industrialized
societies have higher rates of coronary heart disease
than women, differences in levels of HDL cholesterol
might account for much of the contrast.9 The present
results indicate that body fat distribution (or a highly
correlated characteristic) can be an important deter-
minant of male/female differences in levels of triglyc-
erides, HDL cholesterol, total/HDL cholesterol, and
apolipoproteins A-I and B. In this study of 1,124
employed adults, men had higher levels of triglycer-
ides and apolipoprotein B together with lower levels
of HDL cholesterol and apolipoprotein A-I. Control-
ling for WHR in several types of analyses greatly
reduced these sex differences in levels of lipids and
lipoproteins. For example, the male excess in levels
of triglycerides was reduced by 97% with stratifica-
tion, by 94% with analysis of covariance, and by 89%
with a matched-pairs analysis.
Many of the detrimental effects of obesity depend
on the anatomic localization of adipose tissue, with a
relative excess of body fat on the trunk and upper
body associated with adverse levels of lipo-
proteins,15,16 diabetes mellitus,13 and coronary heart
disease.17,18 Although both Quetelet index and WHR
are related to levels of lipids and lipoproteins, the
relative importance of body fat distribution in
explaining the male/female differences in the present
study was remarkable. For example, controlling for
WHR reduced the sex differences in levels of apo-
lipoprotein B and triglycerides by more than 90%,
but adjustment for Quetelet index had no effect.
Furthermore, at comparable levels of WHR, men
and women had similar levels of lipids and lipopro-
teins despite large differences in Quetelet index. In
agreement with these results, Foster et a127 reported
that body fatness (as measured by tritium dilution)
was not related to lipoprotein levels in either sex
after controlling for fat patterning and body build.
WHR is a relatively simple index of upper-body
and abdominal obesity.28 Although waist girth and
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WHR showed comparable associations with levels of
lipids and lipoproteins in the present study, WHR is
less strongly related to Quetelet index and is highly
correlated with the proportion of visceral fat.29 Fur-
thermore, WHR might be a better predictor of
subsequent cardiovascular disease than is waist
circumference.29 Although more accurate measure-
ment of fat distribution (such as a series of skinfold
or circumference measurements or computed tomog-
raphy) might be more predictive of metabolic and
clinical complications,29 31 WHR has been consis-
tently related to adverse levels of triglycerides and
HDL cholesterol.14-16,28,31 In contrast, levels of total
cholesterol are less strongly associated with body fat
distribution,30'32 and mean levels did not differ
between men and women. The relation of behavioral
characteristics to body fat distribution has been pre-
viously examined, and in agreement with the present
results, higher levels of WHR have been found
among cigarette smokers.33-35
There are several mechanisms whereby deposition
of adipose tissue in the abdominal region could result
in metabolic disturbances.14,28 Even after considering
relative weight, decreases in skeletal muscle sensitiv-
ity to insulin and hepatic removal of insulin are seen
in women with abdominal obesity.36 Furthermore,
abdominal fat cells are characterized by relatively
high rates of lipolysis.15 Because free fatty acids from
intra-abdominal adipocytes can drain directly into
the portal circulation, the amount of visceral fat
(which is highly correlated with WHR29,31) might be
the most important aspect of body fat topography.
It is possible, however, that levels of estrogen and
androgens mediate the association between fat pat-
terning and lipoproteins. Sexual maturation in the
female rat is associated with preservation of undif-
ferentiated preadipocytes only in the femoral
region.37 During adolescence, boys deposit more fat
in truncal areas than girls38 and undergo a decrease
in levels ofHDL cholesterol.39 Furthermore, levels of
free testosterone in nonhirsute women are related to
WHR40 and impaired peripheral insulin sensitivity.41
Decreased levels of sex hormone-binding globulin,
reflecting a relative excess of unbound androgen to
estrogen, have also been related to WHR in men40,42
and women4344 and to adverse levels of lipids and
lipoproteins.43 Although few studies have included
measurements of body fat distribution, sex hor-
mones, and levels of lipoproteins, Stefanick et a142
found that controlling for WHR reduced the relation
of sex hormone-binding globulin to levels of triglyc-
erides and HDL2 cholesterol. It is possible that the
relation of fat patterning to lipoprotein levels might
be partly due to their joint association with sex
hormones. Insulin resistance in hyperandrogenized,
nonobese women can be partially overcome by the
administration of an antiandrogen.1"
Despite the pronounced reduction in male/female
differences in lipoprotein levels seen in the present
study, several limitations of its design should be
considered. Subjects were employed volunteers, and
approximately 50% of eligible persons participated.
Although this rate is lower than those seen in
community-based studies,45 it is comparable to other
studies of employed populations.46 Persons with a
history of hyperlipidemia might have been more
likely to have volunteered,47 and a selection bias
would have resulted if participation of these persons
were related to body fat distribution.48 Levels of
several characteristics, however, were comparable
with those reported by other investigators. For exam-
ple, 25-34-year-old men in the present study
(n=249) had mean levels of 25.1 kg/M2 (Quetelet
index), 191 mg/dl (total cholesterol), and 48 mg/dl
(HDL cholesterol) as compared with levels of 25.2
kg/m2, 188 mg/dl, and 45 mg/dl, respectively,
reported by the National Health Survey49 and the
Lipid Research Clinics Prevalence Study.50 Among
similarly aged women (n=152), corresponding levels
were 23.6 kg/M2, 185 mg/dl, and 61 mg/dl in the
present study versus 23.8 kg/M2, 174 mg/dl, and 56
mg/dl. Furthermore, the observed associations
between Quetelet index, cigarette smoking, alcohol
consumption, and exercise with lipid and lipoprotein
levels were comparable with those reported by
others.51 Because of these similarities, it is unlikely
that a selection bias substantially influenced the
results.
The relatively slight overlap of WHR between men
and women might be due to the inclusion of employed
volunteers, and additional studies are needed to extend
the current findings to persons with extreme levels of
WHR. Furthermore, although 74 women were more
than 50 years old, no information was collected on the
use of postmenopausal hormones, which can affect
levels of lipids and lipoproteins.34 (Based on other
studies in Milwaukee,52 about 15% of these older
women might have been using estrogens.) Stratified
analyses, however, showed that adjustment for WHR
reduced the male/female differences in lipoproteins
among younger and older participants. Although it is
also possible that WHR was misclassified, this would
have resulted in the persistence of male/female differ-
ences in lipoprotein levels after controlling for body fat
distribution.
Because of the cross-sectional study design, the tem-
poral relation of body fat distribution to lipoprotein
levels is unclear. However, the large proportion of
differences in lipoprotein levels between men and
women that can be attributed to body fat distribution as
well as the plausible biological mechanisms suggest that
body fat distribution (or a highly related characteristic)
is an important determinant of differences in lipid and
lipoprotein levels between men and women.
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